Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...
The treatment seems to work best in people with mild or moderate arthritis. It may make good sense if you're trying to delay getting surgery on your joint. Generally, health care providers use ...
Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...
The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...
A 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with ... It is approved for use in rheumatoid arthritis, juvenile ...
Although Arthritis Today magazine is no longer published, sign up below to receive healthy living tips and resources in our Arthritis Today and other e-newsletters, delivered right to your inbox.
Canadian Medical Association Journal (CMAJ), Canadian Guideline on HIV Pre-exposure Prophylaxis and Non-occupational Post-exposure Prophylaxis Canadian AIDS Treatment Information Exchange (CATIE) ...
Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in ...